首页> 外文期刊>British journal of sports medicine >Subacromial decompression versus diagnostic arthroscopy for shoulder impingement: a 5-year follow-up of a randomised, placebo surgery controlled clinical trial
【24h】

Subacromial decompression versus diagnostic arthroscopy for shoulder impingement: a 5-year follow-up of a randomised, placebo surgery controlled clinical trial

机译:Subacromial减压与诊断关节镜用于肩部冲击:随机,安慰剂手术控制临床试验的5年随访

获取原文
获取原文并翻译 | 示例
           

摘要

To assess the long-term efficacy of arthroscopic subacromial decompression (ASD) by comparing it with diagnostic arthroscopy (primary comparison), a placebo surgical intervention, and with a non-operative alternative, exercise therapy (secondary comparison).We conducted a multicentre, three group, randomised, controlled superiority trial. We included 210 patients aged 35–65 years, who had symptoms consistent with shoulder impingement syndrome for more than 3 months. 175 participants (83%) completed the 5 years follow-up. Patient enrolment began on 1 February 2005 and the 5-year follow-up was completed by 10 October 2018. The two primary outcomes were shoulder pain at rest and on arm activity measured with Visual Analogue Scale (VAS). Minimally important difference (MID) was set at 15. We used a mixed-model repeated measurements analysis of variance with participant as a random factor, the baseline value as a covariate and assuming a covariance structure with compound symmetry.In the primary intention to treat analysis (ASD vs diagnostic arthroscopy), there were no between-group differences that exceeded the MID for the primary outcomes at 5 years: the mean difference between groups (ASD minus diagnostic arthroscopy) in pain VAS were ?2.0 (95% CI ?8.5 to 4.6; p=0.56) at rest and ?8.0 (?17.3 to 1.3; p=0.093) on arm activity. There were no between-group differences in the secondary outcomes or adverse events that exceeded the MID. In our secondary comparison (ASD vs exercise therapy), the mean differences between groups (ASD minus exercise therapy) in pain VAS were 1.0 (?5.6 to 7.6; p=0.77) at rest and ?3.9 (?12.8 to 5.1; p=0.40) on arm activity. There were no significant between-group differences for the secondary outcomes or adverse events.ASD provided no benefit over diagnostic arthroscopy (or exercise therapy) at 5 years for patients with shoulder impingement syndrome.
机译:通过将其与诊断关节镜(主要比较),安慰剂手术干预和非手术替代,运动疗法(次要比较)进行比较来评估关节镜亚致辐射减压(ASD)的长期疗效。我们进行了多期,三组,随机,受控优势试验。我们包括210名35-65岁的患者,他们患有肩部冲击综合征的症状超过3个月。 175名参与者(83%)完成了5年的随访。患者入学始于2005年2月1日开始,5年后的随访于2018年10月10日完成。两次主要结果是休息休息,并以视觉模拟量表(VAS)测量的臂活动。最小的重要差异(中间)设定为15.我们使用了与参与者作为随机因子的差异分析的混合模型分析,基线值作为协变量,并假设具有复合对称的协方差结构。在初步意图分析(ASD与诊断关节镜检查),在5年内超过了主要结果的组差异:疼痛VAS中群体(ASD减去诊断关节镜检查)的平均差异是?2.0(95%CI?8.5在休息时至4.6; p = 0.56),在ARM活动时静置和α.8.0(?17.3至1.3; p = 0.093)。在超过中期的二次结果或不良事件中没有组差异。在我们的次要比较(ASD与锻炼疗法)中,疼痛VAS中的群体(ASD减去运动疗法)之间的平均差异为1.0(?5.6至7.6; p = 0.77),α3.9(?12.8至5.1; p = 0.40)在ARM活动上。次要结果或不良事件之间没有显着的差异。对于肩部冲击综合征患者,不提供对诊断关节镜(或运动治疗)的诊断关节镜(或运动疗法)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号